A study is underway in Knoxville that's testing a pill version of the COVID-19 vaccine to determine if it's more effective ...

In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...

Pfizer (NYSE: PFE) was on top of the world when it came to earnings and stock price performance. This was in early pandemic ...

Researchers warn that only DTP is on track to reach 90% global coverage by 2030, while measles and pneumococcal vaccines lag behind significantly.

California Gov. Gavin Newsom faced challenging questions from podcaster Joe Rogan about California's pandemic policies in a ...

To understand the new politics stance and other pro nationals of recent times, we should look to Silicon Valley and the ...

Healthcare professionals in Virginia are working to reinforce the vital role of vaccines in protecting the health of the ...

South Carolina confirmed its first case of measles since September 2024 in the worldwide uptick of confirmed cases. Here’s ...

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...

As Professor of Infectious Diseases and Microbiology Paul Griffin explains in a recent piece for The Conversation, Stratus is ...

This stock used to be a highflyer but has struggled in recent years as demand waned for its flagship product. Though Moderna ...

A speechwriter for former President Barack Obama suggested in a guest essay on Sunday that it might be time to stop shunning ...